We are live on
!
Find out more
OAM
Oppenheimer Asset Management Portfolio holdings
AUM
$9.63B
1-Year Est. Return
30.32%
This Fund
S&P 500
This Quarter
Est. Return
+7.72%
1 Year Est. Return
+30.32%
3 Year Est. Return
+85%
5 Year Est. Return
+99.62%
10 Year Est. Return
+601.29%
AUM
$7.02B
AUM Growth
+$570M
(+8.8%)
Cap. Flow
+$123M
Cap. Flow
% of AUM
1.75%
Top 10 Holdings %
Top 10 Hldgs %
15.06%
Holding
1,247
New
85
Increased
719
Reduced
392
Closed
47
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Liberty Global Class C
LBTYK
|
+$10.2M |
| 2 |
VICI Properties
VICI
|
+$8.36M |
| 3 |
Allstate
ALL
|
+$7.41M |
| 4 |
United Therapeutics
UTHR
|
+$6.59M |
| 5 |
Maximus
MMS
|
+$5.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Affiliated Managers Group
AMG
|
+$24.7M |
| 2 |
Magna International
MGA
|
+$8.92M |
| 3 |
Progressive
PGR
|
+$7.03M |
| 4 |
Morgan Stanley
MS
|
+$6.3M |
| 5 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$6.05M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.61% |
| 2 | Healthcare | 13.94% |
| 3 | Financials | 13.92% |
| 4 | Consumer Discretionary | 10.22% |
| 5 | Industrials | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Edgewell Personal Care
EPC
$1.31B
| $250K | ﹤0.01% |
5,700
-81
| -1% | -$3.43K |
|
|
VG
1102
DELISTED
Vonage Holdings Corporation
VG
| $250K | ﹤0.01% |
17,349
+279
| +2% | +$3.81K |
|
1103
TripAdvisor
TRIP
$1.26B
| $249K | ﹤0.01% |
6,167
-167
| -3% | -$7.54K |
|
1104
Amcor
AMCR
$22.1B
| $247K | ﹤0.01% |
4,309
+19
| +0.4% | +$1.13K |
|
1105
Equity Residential
EQR
$25.1B
| $246K | ﹤0.01% |
3,197
-98
| -3% | -$7.41K |
|
|
HES
1106
DELISTED
Hess
HES
| $246K | ﹤0.01% |
+2,813
| New | +$227K |
|
|
PFPT
1107
DELISTED
Proofpoint, Inc.
PFPT
| $245K | ﹤0.01% |
1,415
-23,243
| -94% | -$3.77M |
|
1108
Schwab US Dividend Equity ETF
SCHD
$105B
| $241K | ﹤0.01% |
+9,579
| New | +$242K |
|
1109
Brown-Forman Class B
BF.B
$13.1B
| $239K | ﹤0.01% |
3,190
-48
| -1% | -$3.65K |
|
1110
Shinhan Financial Group
SHG
$35.6B
| $239K | ﹤0.01% |
6,668
-203
| -3% | -$7.29K |
|
1111
Casey's General Stores
CASY
$30.9B
| $238K | ﹤0.01% |
1,227
-147
| -11% | -$31.7K |
|
1112
Churchill Downs
CHDN
$6.12B
| $236K | ﹤0.01% |
2,378
-6,366
| -73% | -$654K |
|
1113
Clorox
CLX
$12.7B
| $233K | ﹤0.01% |
1,298
+79
| +6% | +$14.4K |
|
1114
WD-40
WDFC
$3.15B
| $233K | ﹤0.01% |
908
+13
| +1% | +$3.32K |
|
|
AXON
1115
Axon Enterprise
AXON
$46.4B
| $232K | ﹤0.01% |
+1,313
| New | +$193K |
|
1116
Zurn Elkay Water Solutions
ZWS
$8.53B
| $231K | ﹤0.01% |
9,583
-473
| -5% | -$11.4K |
|
|
NUVA
1117
DELISTED
NuVasive, Inc.
NUVA
| $229K | ﹤0.01% |
3,379
-52
| -2% | -$3.55K |
|
1118
Research Solutions
RSSS
$72.2M
| $228K | ﹤0.01% |
79,640
+6,407
| +9% | +$15.2K |
|
1119
Schwab US Large-Cap Growth ETF
SCHG
$62.8B
| $228K | ﹤0.01% |
12,472
-232
| -2% | -$4.01K |
|
|
SAND
1120
DELISTED
Sandstorm Gold
SAND
| $227K | ﹤0.01% |
28,740
-1,437
| -5% | -$11.6K |
|
|
BHVN
1121
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $223K | ﹤0.01% |
+2,298
| New | +$187K |
|
1122
First American
FAF
$7.58B
| $221K | ﹤0.01% |
+3,549
| New | +$226K |
|
1123
First Hawaiian
FHB
$3.35B
| $221K | ﹤0.01% |
+7,812
| New | +$219K |
|
1124
Tenable Holdings
TENB
$4.01B
| $220K | ﹤0.01% |
+5,322
| New | +$216K |
|
1125
O-I Glass
OI
$1.08B
| $219K | ﹤0.01% |
13,398
+362
| +3% | +$6.13K |
|
Similar funds
TIM
SC
TCA
CCMT
LAMI
BAMF
DCP
HL
Oppenheimer Asset Management's Q2 2021 Portfolio in Review
As of Q2 2021, Oppenheimer Asset Management held 1,247 positions worth $7.02B, up 8.8% from $6.45B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Oppenheimer Asset Management's Q2 2021 filing shows 85 new, 719 increased, 392 reduced and 47 closed positions. Its largest new stake was United Therapeutics: 34,595 shares worth $6.21M. The largest sale was Affiliated Managers Group, an estimated $24.7M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Oppenheimer Asset Management's largest Q2 2021 buy was United Therapeutics: 34,595 shares worth $6.21M.
- Oppenheimer Asset Management added most to Liberty Global Class C in Q2 2021, an estimated $10.2M increase.
- Oppenheimer Asset Management's biggest Q2 2021 reduction was Affiliated Managers Group, cutting an estimated $24.7M.
- Oppenheimer Asset Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $5.92M.
- Oppenheimer Asset Management's ten largest holdings make up 15% of its $7.02B portfolio in Q2 2021.
- Oppenheimer Asset Management opened 85 new positions and closed 47 in Q2 2021.
- Oppenheimer Asset Management's portfolio value rose 8.8% quarter-over-quarter to $7.02B.
Based on Oppenheimer Asset Management's 13F filing for Q2 2021, filed 3 Aug 2021.